Top Markets
Coin of the day
Cellivery Therapeutics, Inc. Cellivery Therapeutics, Inc.

Cellivery Therapeutics, Inc.

268600
Kedudukan dalam Saham #19185
Cellivery Therapeutics, Inc. is dedicated to pioneering therapeutic drugs... Cellivery Therapeutics, Inc. is dedicated to pioneering therapeutic drugs designed to combat critical and often fatal conditions, including various cancers, inflammatory disorders, metabolic diseases, and neurodegenerative ailments. The company leverages its proprietary Therapeutic molecule Systemic Delivery Technology to develop a diverse pipeline of small molecule compounds, antibodies, and vaccines. Established in 2014, this firm is headquartered in Seoul, South Korea.
Harga Saham
$4.62
Disegerakkan terakhir: 2023-03-23
Modal Pasaran
$171.76M
Perubahan (1 hari)
-37.16%
Perubahan (1 tahun)
0.00%
Negara
KR
Perdagangan Cellivery Therapeutics, Inc. (268600)

Kategori

Harga 268600 dengan permodalan pasaran b
Cellivery Therapeutics, Inc. Cellivery Therapeutics, Inc.
268600
$4.62
Modal pasaran bagi Cellivery Therapeutics, Inc.(268600)
Modal Pasaran: $171.76M
Sehingga August 2026, Cellivery Therapeutics, Inc. mempunyai modal pasaran sebanyak $171.76M. Ini menjadikan Cellivery Therapeutics, Inc. syarikat ke-19185th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Cellivery Therapeutics, Inc. dari 2018 hingga 2026
268600 berbanding dengan 5 teratas yang paling popular stocks
Harga 268600 Aset B Pasaran B Hasilnya
Cellivery Therapeutics, Inc. Cellivery Therapeutics, Inc.
$138,570 $171.76M
$5.152T +2,999,785.97%
Cellivery Therapeutics, Inc. Cellivery Therapeutics, Inc.
$122,018 $171.76M
$4.537T +2,641,448.56%
Cellivery Therapeutics, Inc. Cellivery Therapeutics, Inc.
$112,109 $171.76M
$4.169T +2,426,927.41%
Cellivery Therapeutics, Inc. Cellivery Therapeutics, Inc.
$97,956.71 $171.76M
$3.642T +2,120,552.71%
Cellivery Therapeutics, Inc. Cellivery Therapeutics, Inc.
$75,429.19 $171.76M
$2.805T +1,632,857.36%